JP2004517322A5 - - Google Patents

Download PDF

Info

Publication number
JP2004517322A5
JP2004517322A5 JP2002554731A JP2002554731A JP2004517322A5 JP 2004517322 A5 JP2004517322 A5 JP 2004517322A5 JP 2002554731 A JP2002554731 A JP 2002554731A JP 2002554731 A JP2002554731 A JP 2002554731A JP 2004517322 A5 JP2004517322 A5 JP 2004517322A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002554731A
Other versions
JP4348083B2 (ja
JP2004517322A (ja
Filing date
Publication date
Priority claimed from FI20010019A external-priority patent/FI20010019A/fi
Application filed filed Critical
Publication of JP2004517322A publication Critical patent/JP2004517322A/ja
Publication of JP2004517322A5 publication Critical patent/JP2004517322A5/ja
Application granted granted Critical
Publication of JP4348083B2 publication Critical patent/JP4348083B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002554731A 2001-01-05 2002-01-04 萎縮性胃炎の検査方法 Expired - Lifetime JP4348083B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010019A FI20010019A (fi) 2001-01-05 2001-01-05 Menetelmä atrofisen diagnostisoimiseksi
PCT/FI2002/000008 WO2002054084A1 (en) 2001-01-05 2002-01-04 A method for diagnosing atrophic gastritis

Publications (3)

Publication Number Publication Date
JP2004517322A JP2004517322A (ja) 2004-06-10
JP2004517322A5 true JP2004517322A5 (ja) 2005-12-22
JP4348083B2 JP4348083B2 (ja) 2009-10-21

Family

ID=8559891

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002554731A Expired - Lifetime JP4348083B2 (ja) 2001-01-05 2002-01-04 萎縮性胃炎の検査方法

Country Status (7)

Country Link
US (1) US7358062B2 (ja)
EP (1) EP1348129A1 (ja)
JP (1) JP4348083B2 (ja)
CN (1) CN1484765B (ja)
FI (1) FI20010019A (ja)
RU (1) RU2262706C2 (ja)
WO (1) WO2002054084A1 (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2375181T3 (es) 2002-05-09 2012-02-27 The Brigham And Women's Hospital, Inc. 1l 1rl-1 como un marcador de enfermedades cardiovasculares.
FI119571B (fi) * 2002-09-06 2008-12-31 Biohit Oyj Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
EP1608984A2 (en) * 2003-03-28 2005-12-28 Aphton Corporation Gastrin hormone immunoassays
FI119572B (fi) * 2004-03-05 2008-12-31 Biohit Oyj Menetelmä vatsan limakalvon tilan ennustamiseksi
EP1577673B1 (en) * 2004-03-15 2008-07-30 F. Hoffmann-La Roche Ag The use of BNP-type peptides and ANP-type peptides for assessing the risk of suffering from a cardiovascular complication as a consequence of volume overload
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
NZ555926A (en) * 2004-12-20 2008-11-28 Antibodyshop As Determination of neutrophil gelatinase-associated lipocalin (NGAL) as a diagnostic marker for renal disorders
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
US20080090304A1 (en) * 2006-10-13 2008-04-17 Barasch Jonathan Matthew Diagnosis and monitoring of chronic renal disease using ngal
US8340745B2 (en) * 2006-06-05 2012-12-25 Forth Photonics Ltd. Methods for characterizing cancer and pre-cancer tissues
EP2064553B2 (en) * 2006-08-07 2023-06-07 Antibodyshop A/S Diagnostic test to exclude significant renal injury
US20080050749A1 (en) * 2006-08-17 2008-02-28 Ildiko Amann-Zalan Use of bnp-type peptides for the stratification of therapy with erythropoietic stimulating agents
FI20065542A0 (fi) * 2006-09-01 2006-09-01 Biohit Oyj Menetelmä ja näytteenottopakkaus vatsan limakalvon tilan arvioimiseksi
JP2011501177A (ja) * 2007-10-26 2011-01-06 ビオヒット・ユルキネン・オサケユキテュア 自己免疫疾患および萎縮性胃炎と関連する胃癌を診断するための方法および製品
PT2269063E (pt) 2008-04-18 2013-11-27 Critical Care Diagnostics Inc Predição do risco de eventos cardíacos adversos maiores
NZ591981A (en) * 2008-10-01 2013-05-31 Univ Arizona State Glucuronidated acetaminophen as a marker of hepatic disorders
CA2752715C (en) * 2009-04-14 2018-05-01 Arie R. Van Doorn Hifu induced cavitation with reduced power threshold
CN102087279A (zh) * 2010-03-11 2011-06-08 北京美康生物技术研究中心 一种联合诊断胃病或评价胃癌风险的酶联免疫吸附试剂盒
US20130056630A1 (en) * 2010-05-03 2013-03-07 The Cleveland Clinic Foundation Detection and monitoring of nonalcoholic fatty liver disease
US20130079296A1 (en) * 2010-05-31 2013-03-28 Sepstone Diagnostics Sarl Method for assaying lower respiratory tract infection or inflammation
ES2372842B1 (es) * 2010-07-12 2013-08-13 Fundacion De La Comunidad Valenciana Centro De Investigacion Principe Felipe Método ex-vivo para el diagnóstico temprano de la encefalopatía hepática mínima mediante la determinación de 3-nitrotirosina en suero.
RU2465597C1 (ru) * 2011-04-08 2012-10-27 Сергей Михайлович Котелевец Способ определения вероятности развития рака желудка
WO2014031764A1 (en) 2012-08-21 2014-02-27 Critical Care Diagnostics, Inc. Multimarker risk stratification
CN103914997B (zh) * 2014-04-02 2016-03-02 无锡宜偌维盛生物技术有限公司 一种胃功能演示仪
CN105242045A (zh) * 2014-06-13 2016-01-13 拜奥希特公司 胃泌素-17作为具有增加的数种相关后发病风险的萎缩性胃炎的生物标志物的用途
RU2560703C1 (ru) * 2014-09-17 2015-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт молекулярной биологии и биофизики" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИМББ" СО РАМН) Способ выявления дисплазии эпителия слизистой оболочки желудка у пациентов с атрофическим гастритом или аденомой желудка
RU2584750C1 (ru) * 2015-05-22 2016-05-20 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт молекулярной биологии и биофизики" (НИИМББ) Способ выявления дисплазии эпителия слизистой оболочки желудка при ее атрофических изменениях
CN106198986A (zh) * 2016-08-31 2016-12-07 潍坊市康华生物技术有限公司 联合诊断胃病的化学发光检测试剂盒及其制备、使用方法
EP3296746A1 (en) * 2016-09-20 2018-03-21 Université de Bourgogne In vitro method for diagnosing at early stage intestinal ischemia
JP6885581B2 (ja) * 2017-02-06 2021-06-16 学校法人東京歯科大学 ガストリン測定におけるカットオフ値の推定方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656025A (en) * 1985-04-19 1987-04-07 Emmanuel Deutsch Quantitative screening assay of tumor globulin from gastric juice
AU3728293A (en) * 1992-02-26 1993-09-13 Vanderbilt University Purified vacuolating toxin from (helicobacter) pylori and methods to use same
FI97304C (fi) 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
CN1178523A (zh) * 1995-03-14 1998-04-08 第一制药株式会社 氨基酚衍生物
JP2949474B2 (ja) 1995-08-28 1999-09-13 隆久 古田 ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法
US6852487B1 (en) * 1996-02-09 2005-02-08 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
FI990991A (fi) * 1999-04-30 2000-10-31 Locus Genex Oy Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi
FI118653B (fi) 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi
US7179609B1 (en) * 2000-10-04 2007-02-20 Atrophus Ab Screening method for gastritis

Similar Documents

Publication Publication Date Title
BE2019C547I2 (ja)
BE2019C510I2 (ja)
BE2018C021I2 (ja)
BE2017C049I2 (ja)
BE2017C005I2 (ja)
BE2016C069I2 (ja)
BE2016C040I2 (ja)
BE2016C013I2 (ja)
BE2018C018I2 (ja)
BE2016C002I2 (ja)
BE2015C078I2 (ja)
BE2015C017I2 (ja)
BE2014C053I2 (ja)
BE2014C051I2 (ja)
BE2014C041I2 (ja)
BE2014C030I2 (ja)
BE2014C016I2 (ja)
BE2014C015I2 (ja)
BE2013C063I2 (ja)
BE2013C039I2 (ja)
BRPI0302144B1 (ja)
BRPI0215435A2 (ja)
BE2013C046I2 (ja)
BR0315835A2 (ja)
AU2001279159A1 (ja)